Adenocarcinoma of the lung: Difference between revisions
Jump to navigation
Jump to search
→Lepidic pattern on biopsy: tweak |
|||
| (2 intermediate revisions by the same user not shown) | |||
| Line 85: | Line 85: | ||
*[[Squamous cell carcinoma of the lung]]. | *[[Squamous cell carcinoma of the lung]]. | ||
*[[Small cell carcinoma of the lung]]. | *[[Small cell carcinoma of the lung]]. | ||
*[[Adenoid | *[[Adenoid cystic carcinoma]]. | ||
*[[Non-small cell lung carcinoma]] - diagnosis should be avoided if possible. | *[[Non-small cell lung carcinoma]] - diagnosis should be avoided if possible. | ||
*[[Malignant mesothelioma]]. | *[[Malignant mesothelioma]]. | ||
| Line 249: | Line 249: | ||
NEGATIVE: p40. | NEGATIVE: p40. | ||
The findings are in keeping with lepidic pattern adenocarcinoma | The findings are in keeping with lepidic pattern adenocarcinoma; the differential diagnosis includes: (1) adenocarcinoma in situ, (2) minimally invasive adenocarcinoma, and (3) invasive adenocarcinoma. | ||
Lung biomarkers (EGFR, ALK, PDL1, ROS1) have been ordered. | Lung biomarkers (EGFR, ALK, PDL1, ROS1) have been ordered. | ||